Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor for Coronary Stenting Post Thrombolysis
NCT01930591Phase 3Completed
- Sponsor
- Unity Health Toronto
- Start
- May 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ticagrelor in ST elevation myocardial infarction (STEMI), sponsored by Unity Health Toronto. Started May 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01930591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01930591.